The global histology and cytology market size
is expected to reach USD 26.9 billion by 2025, according to a new report by
Grand View Research, Inc. Globally, the increasing incidence of cancer and
growing adoption of cytological tests due to its less invasive nature as
compared to biopsy & higher reliability are likely to drive the market
during the forecast period.
Furthermore, rising well-equipped clinical
laboratories in developing countries and favorable reimbursement for cancer
screening and laboratory tests are likely to positively affect the market
growth. Advancements in the cytology and histology save the time for
pathologists, hence this makes the service more cost-effective.
Cytology was the largest segment in the
histology and cytology market in 2016 and is expected to maintain its dominance
during the forecast period due to the recent entry of various tests for
cytological testing and advantages over histology such as faster analysis and
economical technique.
Cytology is further segmented into
cervical, breast, and other cancers based on its application. Cervical cancer
segment dominated in 2016 due to higher incidence and growing demand of test
for the cervical cancer screening. Furthermore, breast cancer was considered as
the second largest segment due to rising awareness about breast cancer screening
in emerging countries.
Browse full report by Grand View
Research : http://www.grandviewresearch.com/industry-analysis/histology-and-cytology-market
Further Key Findings From the Report Suggest:
·
Rising incidence of cancer and growing
investment by players are expected to propel growth at the fastest rate with a
CAGR of 13.5% from 2017 to 2025
·
Cytology testing segment dominated in 2016
and is estimated to account for majority of the share by 2025.
·
Cytological testing for cervix is the
largest contributing segment of the market. This can be attributed to high
incidence and more adoption of the test for cervix screening.
·
The U.S. market was the largest in 2016 and
is expected to maintain its dominance during forecast period due to higher
awareness about screening and higher healthcare expenditure as compared to the
developing countries.
·
In February 2014, Roche launched a new test
for cervical cancer screening, Automated CINtec PLUS cytology test, which
improves the detection of cervical precancer.
·
The industry in Asia Pacific is projected
to witness substantial growth over the next decade owing to growing investment
by several clinics in the region, growing healthcare expenditure, and
increasing adoption of screening tests.
·
Some of the key players operating are
Abbott Laboratories; Becton, Dickinson and Company; F. Hoffmann-La Roche Ltd.;
Hologic, Inc.; Life Technologies Corporation; Sysmex Corporation; Thermo Fisher
Scientific, Inc.; and Trivitron Healthcare.
Browse more reports of this category by Grand View
Research: https://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the
global histology and cytology market on the basis of type of examination and
region:
Type of Examination Outlook (Revenue, USD Million, 2014 -
2025)
·
Cytology
·
Cervical Cancer
·
Breast Cancer
·
Other Players
·
Histology
Regional Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o U.S.
o Canada
·
Europe
o U.K.
o Germany
·
Asia Pacific
o Japan
o China
·
Central & South America
o Brazil
o Mexico
·
Middle East & Africa
o South Africa
Access press release
by Grand View Research: https://www.grandviewresearch.com/press-release/global-histology-cytology-market
About Grand View
Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information:
http://www.grandviewresearch.com
